- Home
- GFL vs ICLR Comparison
GFL vs ICLR Comparison
Compare GFL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFL
- ICLR
- Stock Information
- Founded
- GFL 2007
- ICLR 1990
- Country
- GFL Canada
- ICLR Ireland
- Employees
- GFL N/A
- ICLR N/A
- Industry
- GFL
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- GFL
- ICLR Health Care
- Exchange
- GFL Nasdaq
- ICLR Nasdaq
- Market Cap
- GFL 17.5B
- ICLR 14.5B
- IPO Year
- GFL 2020
- ICLR 1998
- Fundamental
- Price
- GFL $50.49
- ICLR $158.44
- Analyst Decision
- GFL Strong Buy
- ICLR Buy
- Analyst Count
- GFL 8
- ICLR 13
- Target Price
- GFL $57.63
- ICLR $211.92
- AVG Volume (30 Days)
- GFL 1.1M
- ICLR 1.7M
- Earning Date
- GFL 07-30-2025
- ICLR 07-23-2025
- Dividend Yield
- GFL 0.12%
- ICLR N/A
- EPS Growth
- GFL N/A
- ICLR 13.11
- EPS
- GFL 6.79
- ICLR 9.73
- Revenue
- GFL $5,927,221,266.00
- ICLR $8,089,820,000.00
- Revenue This Year
- GFL N/A
- ICLR N/A
- Revenue Next Year
- GFL $6.46
- ICLR $1.72
- P/E Ratio
- GFL $7.10
- ICLR $16.22
- Revenue Growth
- GFL 19.12
- ICLR N/A
- 52 Week Low
- GFL $38.29
- ICLR $125.10
- 52 Week High
- GFL $52.00
- ICLR $328.35
- Technical
- Relative Strength Index (RSI)
- GFL 59.77
- ICLR 48.02
- Support Level
- GFL $49.43
- ICLR $154.69
- Resistance Level
- GFL $50.94
- ICLR $168.17
- Average True Range (ATR)
- GFL 0.87
- ICLR 8.27
- MACD
- GFL 0.34
- ICLR -2.61
- Stochastic Oscillator
- GFL 88.81
- ICLR 13.84
About GFL GFL Environmental Inc. Subordinate voting shares no par value
GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. The company's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.